JULIE CARBRAY: Open Payments
NPI 1639261837 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,902 in 22 payments from 6 companies in 2025. Trend: 2023 $3,043 · 2024 $18,600 · 2025 $12,902
Consulting: $11,690Food & beverage: $966Travel & lodging: $246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $9,327 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $2,915 |
| ACADIA Pharmaceuticals Inc | 3 | $268 |
| Alkermes, Inc. | 2 | $196 |
| Neurocrine BioSciences, Inc. | 3 | $145 |
| Supernus Pharmaceuticals, Inc. | 1 | $52 |
Products named: VRAYLAR, NUPLAZID, Ingrezza, ARISTADA, LYBALVI, Qelbree.
Industry payments across IL — which companies pay providers there.
